Invention Grant
- Patent Title: EZH2 inhibitors
-
Application No.: US15921097Application Date: 2018-03-14
-
Publication No.: US10266542B2Publication Date: 2019-04-23
- Inventor: Matthew Arnold Marx , Matthew Randolph Lee , Robert Anthony Galemmo , Thomas P. Bobinski
- Applicant: Mirati Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Mirati Therapeutics, Inc.
- Current Assignee: Mirati Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Main IPC: C07D491/048
- IPC: C07D491/048 ; C07D519/00 ; C07D471/04 ; C07D495/04 ; C07D498/04 ; C07D513/04 ; A61P35/00
Abstract:
The present invention relates to compounds that inhibit EZH2 activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
Public/Granted literature
- US20180265517A1 EZH2 Inhibitors Public/Granted day:2018-09-20
Information query
